FORM 10-Q



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


          QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934


         (Mark One)
         { X }  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                SECURITIES EXCHANGE ACT OF 1934

         For the quarterly period ended                June 30, 2003

         {   }  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                SECURITIES EXCHANGE ACT OF 1934

         For the transition period from                     to


   For Quarter Ended     June 30, 2003       Commission file number   000-17596

         Meridian Healthcare Growth and Income Fund Limited Partnership
             (Exact Name of Registrant as Specified in its Charter)


           Delaware                                          52-1549486
   (State or Other Jurisdiction of                       (I.R.S. Employer
   Incorporation or Organization)                     Identification Number)



    225 East Redwood Street, Baltimore, Maryland               21202
      (Address of Principal Executive Offices)               (Zip Code)

       Registrant's Telephone Number, Including Area Code: (410) 727-4083

                                       N/A
              (Former Name, Former Address, and Former Fiscal Year,
                         if Changed Since Last Report.)

           Indicate by check mark whether the registrant (1) has filed all
         reports required to be filed by Section 13 or 15 (d) of the Securities
         Exchange Act of 1934 during the preceding 12 months (or for such
         shorter period that the registrant was required to file such reports),
         and (2) has been subject to such filing requirements for the past 90
         days.

                             Yes     X                      No

           Indicate by check mark whether the registrant is an accelerated filer
         (as defined in Rule 12b-2 of the Act).

                             Yes                            No     X


<PAGE>



         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                                      INDEX


                                                                        Page No.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS                      2

Part I.  Financial Information


     Item 1.  Financial Statements

              Condensed Consolidated Balance Sheets                            3
              Condensed Consolidated Statements of Earnings                    4
              Condensed Consolidated Statements of Partners' Capital           5
              Condensed Consolidated Statements of Cash Flows                  6
              Notes to Condensed Consolidated Financial Statements           7-9


     Item 2.  Management's Discussion and Analysis of
                 Financial Condition and Results of Operations             10-13


     Item 3.  Quantitative and Qualitative Disclosures
                 About Market Risk                                            14


    Item 4.   Controls and Procedures14

Part II.   Other Information


     Item 1. through Item 6.                                               14-21

     Signatures                                                               22





<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP



            Cautionary Statement Regarding Forward Looking Statements

Statements made in this report, and in our other public filings, which are not
historical facts contain "forward-looking" statements (as defined in the Private
Securities Litigation Reform Act of 1995) that involve risks and uncertainties
and are subject to change at any time. These forward-looking statements may
include, but are not limited to:

o    certain statements in "Management's Discussion and Analysis of Financial
     Condition and Results of Operations," such as our ability to meet our
     liquidity needs, scheduled debt and interest payments and expected future
     capital expenditure requirements and the expected effects of government
     regulation on reimbursement for services provided; and

o   certain statements in the Notes to Condensed Consolidated Financial
    Statements (Unaudited).

 The forward-looking statements involve known and unknown risks, uncertainties
 and other factors that are, in some cases, beyond our control. You are
 cautioned that these statements are not guarantees of future performance and
 that actual results and trends in the future may differ materially.

 Factors that could cause actual results to differ materially include, but are
not limited to the following:

o     changes in the reimbursement rates or methods of payment from Medicare and
      Medicaid, or the implementation of other measures to reduce the
      reimbursement for our services;

o    the expiration of enactments providing for additional governmental funding;

o    efforts of third party payors to control costs;

o    the impact of federal and state regulations;

o    changes in payor mix and payment methodologies;

o    further consolidation of managed care organizations and other third party
     payors;

o    competition in our business;

o    an increase in insurance costs and potential liability for losses not
     covered by, or in excess of, our insurance;

o    competition for qualified staff in the healthcare industry;

o    our ability to control operating costs, and generate sufficient cash flow
     to meet operational and financial requirements; and

o    an economic downturn or changes in the laws affecting our business in those
     markets in which we operate.

 These risks are described in more detail in our Annual Report on Form 10-K.

In addition to these factors and any risks and uncertainties specifically
identified in the text surrounding forward-looking statements, any statements in
this report or the reports and other documents filed by us with the SEC that
warn of risks or uncertainties associated with future results, events or
circumstances also identify factors that could cause actual results to differ
materially from those expressed in or implied by the forward-looking statements.

 All subsequent written and oral forward-looking statements attributable to us
 or any person acting on our behalf are expressly qualified in their entirety by
 the cautionary statements contained or referred to in this section. We do not
 undertake any obligation to release publicly any revisions to these
 forward-looking statements to reflect events or circumstances after the date of
 this report or to reflect the occurrence of unanticipated events, except as may
 be required under applicable securities law.





                                        2

<PAGE>
         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP
                      Condensed Consolidated Balance Sheets
                             (Dollars in thousands)
<TABLE>
<CAPTION>
                                                                  June 30,
                                                                    2003          December 31,
                                                                 (Unaudited)
2002
                                                            ----------------   ---------------
Assets
Current Assets
<S>                                                           <C>                <C>
   Cash and cash equivalents                                  $           816    $          740
   Accounts receivable, net                                             7,612             7,809
   Estimated third-party payor settlements                                483               840
   Prepaid expenses and other current assets                              776               766
                                                              ----------------   ---------------
       Total current assets                                             9,687            10,155
                                                              ----------------   ---------------

Property and equipment, net of accumulated depreciation                30,919            31,231
                                                              ----------------   ---------------

Other assets
   Goodwill, net                                                        4,237             4,237
   Loan acquisition costs, net                                            383               216
                                                              ----------------   ---------------
                                                                        4,620             4,453
                                                              ----------------   ---------------


       Total assets                                           $        45,226    $       45,839
                                                              ================   ===============

Liabilities and Partners' Capital
Current liabilities
   Current portion of long-term debt                          $           689    $          606
   Line of credit                                                         227                 -
   Accrued compensation and related costs                                 103                 3
   Accounts payable and other accrued expenses                          2,730             2,808
   Estimated third party payor settlements                              2,265             2,527
                                                              ----------------   ---------------
       Total current liabilities                                        6,014             5,944
                                                              ----------------   ---------------

Deferred management fee payable                                         1,042             1,021
Loan payable to the Development General Partner                         1,317             1,292
Long-term debt                                                         21,864            22,271
                                                              ----------------   ---------------
                                                                       24,223            24,584
                                                              ----------------   ---------------

Partners' capital
   General partners                                                      (165)             (162)
   Assignee limited partners; 1,540,040
     units issued and outstanding                                      15,154            15,473
                                                              ----------------   ---------------
       Total partners' capital                                         14,989            15,311
                                                              ----------------   ---------------

       Total liabilities and
         partners' capital                                    $        45,226    $       45,839
                                                              ================   ===============

</TABLE>



     See accompanying notes to condensed consolidated financial statements.

                                       -3-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP
                  Condensed Consolidated Statements of Earnings
                                   (Unaudited) (Dollars in thousands except per
                 unit amounts)
<TABLE>
<CAPTION>

                                                            Three Months Ended                    Six Months Ended
                                                   ----------------------------------   ----------------------------------

                                                        June 30,          June 30,           June 30,          June 30,
                                                          2003              2002               2003              2002
                                                    ---------------   ----------------   ----------------   ---------------

Revenues
<S>                                                 <C>               <C>                <C>                <C>
   Medicaid and Medicare patients                   $       13,299    $        13,105    $        26,385    $       25,638
   Private patients                                          2,027              2,292              4,330             4,802
   Investment and other income                                  17                 29                 35                54
                                                    ---------------   ----------------   ----------------   ---------------
                                                            15,343             15,426             30,750            30,494
                                                    ---------------   ----------------   ----------------   ---------------

Expenses
   Operating, including $2,486, $2,776, $4,989
       and $5,281 to related parties, respectively          12,973             12,704             26,162            24,757
   Management and administration fees
       to related parties                                      800                853              1,633             1,682
   General and administrative                                  273                284                375               542
   Depreciation and amortization                               521                507              1,025             1,008
   Interest expense                                            398                595                856             1,187
                                                    ---------------   ----------------   ----------------   ---------------
                                                            14,965             14,943             30,051            29,176
                                                    ---------------   ----------------   ----------------   ---------------

Net earnings                                        $          378    $           483    $           699    $        1,318
                                                    ===============   ================   ================   ===============


Net earnings per unit of assignee
   limited partnership interest
   (computed based on 1,540,040
    units)                                          $         0.24    $          0.31    $          0.45    $         0.85
                                                    ===============   ================   ================   ===============
</TABLE>


      See accompanying notes to condensed consolidated financial statements

                                       -4-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP
             Condensed Consolidated Statements of Partners' Capital
                 For the Six Months Ended June 30, 2003 and 2002
                                   (Unaudited)
                             (Dollars in thousands)


<TABLE>
<CAPTION>
                                                                        Assignee
                                                General            Limited
                                               Partners           Partners            Total
                                           ----------------   ----------------   ---------------

<S>                                        <C>                <C>                        <C>
Balance at December 31, 2002               $          (162)   $        15,473            15,311

Net earnings                                             7                692               699

Distributions to partners                              (10)            (1,011)           (1,021)
                                           ----------------   ----------------   ---------------

Balance at June 30, 2003                   $          (165)   $        15,154            14,989
                                           ================   ================   ===============





Balance at December 31, 2001               $          (153)   $        16,386            16,233

Net earnings                                            13              1,305             1,318

Distributions to partners                              (17)            (1,636)           (1,653)
                                           ----------------   ----------------   ---------------

Balance at June 30, 2002                   $          (157)   $        16,055            15,898
                                           ================   ================   ===============
</TABLE>






      See accompanying notes to condensed consolidated financial statements

                                       -5-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMTIED PARTNERSHIP
                 Condensed Consolidated Statements of Cash Flows
                        For the Six Months Ended June 30,
                                   (Unaudited)
                             (Dollars in thousands)

<TABLE>
<CAPTION>
                                                                                 2003              2002
                                                                          ----------------   ---------------
Cash flows from operating activities
<S>                                                                        <C>                <C>
   Net earnings                                                            $           699    $        1,318
   Adjustments to reconcile net earnings to net cash
     provided by operating activities
       Depreciation and amortization                                                 1,025             1,008
       Minority interest in net earnings of operating partnerships                       6                12
       Increase in loan payable to Development General Partner                          25                26
       Increase in deferred management fee payable                                      21                22
       Change in other assets and liabilities
         Accounts receivable                                                           191             1,183
         Estimated third-party payor settlements                                        95              (310)
         Prepaid expenses and other current assets                                     (10)              (95)
         Accrued compensation and related costs                                        100             2,584
         Accounts payable and other accrued expenses                                   (78)           (1,364)
                                                                           ----------------   ---------------

Net cash provided by operating activities                                            2,074             4,384
                                                                           ----------------   ---------------

Cash flows from investing activities -
   additions to property and equipment                                                (653)             (715)
                                                                           ----------------   ---------------


Cash flows from financing activities
   Repayment of long-term debt                                                        (324)             (239)
   Loan acquisition costs                                                             (227)                -
   Borrowings under line of credit                                                     227                 -
   Distributions to partners                                                        (1,021)           (1,653)
                                                                           ----------------   ---------------

Net cash used in financing activities                                               (1,345)           (1,892)
                                                                           ----------------   ---------------

Net increase in cash and cash equivalents                                               76             1,777
Cash and cash equivalents
   Beginning of period                                                                 740             2,066
                                                                           ----------------   ---------------

   End of period                                                           $           816    $        3,843
                                                                           ================   ===============

</TABLE>



     See accompanying notes to condensed consolidated financial statements.

                                       -6-


<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP



              Notes to Condensed Consolidated Financial Statements
                                  June 30, 2003
                                   (Unaudited)

NOTE 1 - THE FUND AND BASIS OF PREPARATION

     Meridian  Healthcare Growth and Income Fund Limited  Partnership (the Fund)
was  organized  under the laws of the State of  Delaware  and will  continue  to
operate through December 31, 2037, unless terminated sooner under the provisions
of the Partnership Agreement. The Fund's Administrative General Partner is Brown
Healthcare,  Inc.  and  the  Fund's  Development  General  Partner  is  Meridian
Healthcare  Investments,  Inc. Brown Healthcare  Holding Co., Inc. is the Fund's
Assignor Limited Partner. Meridian Healthcare Investments,  Inc. is a subsidiary
of Genesis Health Ventures, Inc. (Genesis).

The Fund owns 98.99% limited partnership interests in each of the seven
operating partnerships. The Fund, through its seven operating partnerships,
derives substantially all of its revenue from extended healthcare provided to
nursing center residents including room and board, nursing care, drugs and other
medical services.

The accompanying condensed consolidated financial statements of Meridian
Healthcare Growth and Income Fund Limited Partnership (the "Fund") do not
include all of the information and note disclosures normally included in
financial statements prepared in accordance with accounting principles generally
accepted in the United States of America. The unaudited interim condensed
consolidated financial statements reflect all adjustments which are, in the
opinion of management, necessary to a fair statement of the results for the
interim periods presented. All such adjustments are of a normal recurring
nature.

The accompanying unaudited condensed consolidated financial statements should be
read in conjunction with the consolidated financial statements and the notes
thereto included in the Fund's Annual Report on Form 10-K for the fiscal year
ended December 31, 2002.

The Fund has made a number of estimates relating to the reporting of assets and
liabilities, revenues and expenses and the disclosure of contingent assets and
liabilities to prepare these unaudited condensed consolidated financial
statements in conformity with accounting principles generally accepted in the
United States of America. Actual results could differ from those estimates.

NOTE 2 - RELATED PARTY TRANSACTIONS

The Fund is obligated to pay Brown-Healthcare, Inc. (Administrative General
Partner) an annual administration fee of the greater of $75,000 per year or 1/2
of 1% of the Fund's annual revenues. The nursing centers owned by the operating
partnerships are managed by Meridian Healthcare, Inc., an affiliate of Meridian
Healthcare Investments, Inc. (Development General Partner), under the terms of
existing management agreements which provide for management fees equal to 5% of
the annual revenues of each nursing center. Certain of the operating
partnerships also purchase drugs and medical supplies and other services from
affiliates of the Development General Partner. Such purchases are in turn billed
to patients or third party payors at prices which on average approximate the
nursing center's cost.

Transactions with these related parties for the three and six months ended June
30, 2003 and 2002 are as follows:
<TABLE>
<CAPTION>

                                                    Three Months Ended                   Six Months Ended
                                             June 30, 2003     June 30, 2002     June 30, 2003     June 30, 2002

<S>                                            <C>               <C>               <C>              <C>
    Management and administration fees         $ 800,000         $ 853,000         $1,633,000       $1,682,000
    Drug and medical supplies purchases          813,000         1,081,000          1,722,000        1,997,000
    Nursing and rehabilitation services        1,673,000         1,695,000          3,267,000        3,284,000
    Interest expense on borrowings                23,000            23,000             46,000           44,000

</TABLE>


                                        7

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP

              Notes to Condensed Consolidated Financial Statements
                                  June 30, 2003
                                   (Unaudited)

NOTE 2 - RELATED PARTY TRANSACTIONS (Continued)

The Development General Partner loaned the Fund $597,000, as required by the
Cash Flow Deficit Guaranty Agreement, to support the operating deficits
generated by the Mooresville, Salisbury and Woodlands nursing centers during
each center's first two years of operations subsequent to the Fund's acquisition
of partnership interests. Loans outstanding under this arrangement, including
accumulated interest from inception of the loan at 9% per annum, were $1,317,000
at June 30, 2003 and $1,292,000 at December 31, 2002. The Fund is obligated to
repay these loans when certain specified financial criteria are met, the most
significant of which is the payment of a preferred return to the assignee
limited partners as defined in the Fund's partnership agreement.

NOTE 3 - DEBT

The Fund closed its mortgage loan refinancing with a new bank for loans totaling
$24,000,000 on June 12, 2000. The renewal terms became effective on June 12,
2000 and provide for a term of five years at an interest rate of 9.75%. Monthly
payments of $229,886 are based on a 20-year amortization schedule with a balloon
payment due at the end of the 5-year term. Effective February 1, 2003, the Fund
amended the existing mortgage. The amendment provides for a term of five years
at an interest rate of 6.5%. Monthly payments of $180,242 are based on a 20-year
amortization schedule with a mandatory prepayment option at the Bank's
discretion during the period between November 1, 2007 through May 1, 2008.

The Fund established a $4,000,000 revolving credit facility with the same
lender. As of June 30, 2003, the Fund had borrowed $227,000 under this credit
facility to fund financing fees incurred in connection with the amendment of
mortgage terms. Borrowings under the credit facility bears interest at a
floating rate, which equals the announced commercial prime rate. The bank can
renew the credit facility each year for a one-year extension.

NOTE 4 - CERTAIN SIGNIFICANT RISKS AND UNCERTAINTIES

The Fund receives revenues from Medicare, Medicaid, private insurance, self-pay
residents, and other third party payors. The Medicaid and Medicare programs are
highly regulated. The failure of the Fund to comply with applicable
reimbursement regulations could adversely affect its business. The Fund monitors
its receivables from third party payor programs and reports such revenues at the
net realizable value expected to be received.

On December 15, 2000, Congress passed the Benefits Improvement Protection Act
that increased the nursing component of the federal prospective payment system's
rates by 16.7% (approximate) for the period from April 1, 2001 through September
30, 2002. The legislation also changed the 20% add-on to 3 of the 14
rehabilitation resource utilization group categories to a 6.7% add-on to all 14
rehabilitation resource utilization group categories beginning April 1, 2001.
The Medicare Part B consolidated billing provision of the Balance Budget
Refinement Act was repealed except for Medicare Part B therapy services and the
moratorium on the $1,500 therapy caps was extended through calendar year 2002.
These changes had a positive impact on operating results.

         A number of provisions of the Balance Budget Refinement Act and the
Benefits Improvement and Protection Act enactments, providing additional funding
for Medicare participating skilled nursing facilities, expired on September 30,
2002 (the Skilled Nursing Facility Medicare Cliff). Effective October 1, 2002,
Medicare rates adjusted for the Skilled Nursing Facility Medicare Cliff were
increased by a 2.6% annual market basket adjustment. For the Fund, the net
impact of these provisions is estimated to adversely impact annual revenue
beginning October 1, 2002 by approximately $1.2 million.

         On August 4, 2003, the Centers for Medicare & Medicaid Services (CMS)
published in the Federal Register the final fiscal year 2004 skilled nursing
facility prospective payment system rules effective October 1, 2003. The final
rules make two significant enhancements to the market basket adjusting the
fiscal year 2004 base rates by 6.26% (3% increase in the annual update factor
and a 3.26% upward adjustment correcting for previous forecast errors). These
two changes are estimated to increase Medicare payment rates per patient day by
$19. The final rules also provide for the continuation through fiscal year 2004
of certain payment add-ons which were authorized in the Balanced Budget
Refinement Act of 1999 to compensate for non-therapy ancillaries.



                                        8
<PAGE>
         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP

              Notes to Condensed Consolidated Financial Statements
                                  June 30, 2003
                                   (Unaudited)

NOTE 4 - CERTAIN SIGNIFICANT RISKS AND UNCERTAINTIES  (Continued)

 It is not possible to fully quantify the effect of potential legislative or
regulatory changes, the administration of such legislation or any other
governmental initiatives on the Fund's business. Accordingly, there can be no
assurance that the impact of these changes or any future healthcare legislation
will not further adversely affect the Fund's business. There can be no assurance
that payments under governmental and private third party payor programs will be
timely, will remain at levels comparable to present levels or will, in the
future, be sufficient to cover the costs allocable to patients eligible for
reimbursement pursuant to such programs. The Fund's financial condition and
results of operations may be affected by the reimbursement process, which in the
healthcare industry is complex and can involve lengthy delays between the time
that revenue is recognized and the time that reimbursement amounts are settled.


                                        9

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations



Liquidity and Capital Resources

     The Fund closed its mortgage loan refinancing with a new bank for loans
totaling $24,000,000 on June 12, 2000. The renewal terms became effective on
June 12, 2000 and provided for a term of five years at an interest rate of
9.75%. Monthly payments were based on a 20-year amortization schedule with a
balloon payment due at the end of the 5-year term. Effective February 1, 2003,
the Fund amended the existing mortgage. The amendment provides for a term of
five years at an interest rate of 6.5%. Monthly payments of $180,242 are based
on a 20-year amortization schedule with a mandatory prepayment option at the
Bank's discretion during the period between November 1, 2007 through May 1,
2008.

     The Fund also has a $4,000,000 line of credit with the same lender under
terms similar to the mortgage loan terms described above, except that the line
of credit facility requires annual reaffirmation. As of June 30, 2003, the Fund
had borrowed $227,000 under this credit facility to fund financing fees incurred
in connection with the amendment of mortgage terms, discussed above. The Fund
will perform approximately $1 million of non-routine capital improvements to
enhance the functionality and marketability of its Maryland centers. The Fund
expects to draw on its line of credit facility to fund these improvements, as
necessary.

     The Fund's working capital (excluding the current portion of long-term
debt) decreased $455,000 to $4,362,000 at June 30, 2003 as compared to
$4,817,000 at December 31, 2002. The Fund has sufficient liquid assets and other
available credit resources to satisfy its operating expenditures and anticipated
routine capital improvements at each of the seven nursing home facilities.

     Cash flow from operating activities was $2,074,000 for the six-month period
ended June 30, 2003 as compared to $4,384,000 for the same period of 2002. This
decrease in cash flow was due primarily to decreased accounts receivable
collections and lower accrued compensation and related costs, offset by lower
payments of accounts payable and other accrued expenses resulting from timing of
payments.

     Cash used in investing activities for the six-month period ended June 30,
2003 was $653,000 and included improvements to the Fund's seven operating
facilities. Similar improvements made during the first six months of 2002 were
$715,000.

     Cash used in financing activities for the six-month period ended June 30,
2003 was $1,345,000 and included the repayment of long term debt of $324,000 and
distributions to partners totaling $1,021,000.

     The Fund believes that the short-term liquidity needs will be met through
expected cash flow from operations and available working capital from the
existing revolving credit facility.

     Between 1988 and 1989 the Development General Partner loaned the Fund
$597,000 to support operating deficits generated by the Mooresville, Salisbury
and Woodlands nursing centers during each centers' first two years of operation.
Loans outstanding under this arrangement, including interest at 9% per annum,
were $1,317,000 at June 30, 2003 and $1,292,000 at December 31, 2002.

     On August 15, 2003 the Fund will make its second quarter 2003 distribution
to partners of $583,000, representing a 6% return. Based on operating results
through the second quarter and the outlook for the final two quarters of 2003,
the Fund expects a similar distribution throughout the remainder of the year.

     The major challenge to the Fund in the foreseeable future is to control
operating expenses, to maintain a quality mix of patients and to increase the
overall census at each of the facilities.



                                       10


<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations

Revenue Sources

     The Fund receives revenues from Medicare, Medicaid, private insurance,
self-pay residents, and other third party payors. The healthcare industry is
experiencing the effects of the federal and state governments' trend toward cost
containment, as government and other third party payors seek to impose lower
reimbursement and utilization rates and negotiate reduced payment schedules with
providers. These cost containment measures, combined with the increasing
influence of managed care payors and competition for patients, have resulted in
constrained rates of reimbursement for services provided by the Fund.

     A number of provisions of the Balance Budget Refinement Act and the
Benefits Improvement and Protection Act enactments, providing additional funding
for Medicare participating skilled nursing facilities, expired on September 30,
2002 (the Skilled Nursing Facility Medicare Cliff). Effective October 1, 2002,
Medicare rates adjusted for the Skilled Nursing Facility Medicare Cliff were
increased by a 2.6% annual market basket adjustment. For the Fund, the net
impact of these provisions is estimated to adversely impact annual revenue
beginning October 1, 2002 by approximately $1.2 million.

     On August 4, 2003, the Centers for Medicare & Medicaid Services (CMS)
published in the Federal Register the final fiscal year 2004 skilled nursing
facility prospective payment system rules effective October 1, 2003. The final
rules make two significant enhancements to the market basket adjusting the
fiscal year 2004 base rates by 6.26% (3% increase in the annual update factor
and a 3.26% upward adjustment correcting for previous forecast errors). These
two changes are estimated to increase Medicare payment rates per patient day by
$19. The final rules also provide for the continuation through fiscal year 2004
of certain payment add-ons which were authorized in the Balanced Budget
Refinement Act of 1999 to compensate for non-therapy ancillaries.

     It is not possible to fully quantify the effect of potential legislative or
regulatory changes, the administration of such legislation or any other
governmental initiatives on the Fund's business. Accordingly, there can be no
assurance that the impact of these changes or any future healthcare legislation
will not further adversely affect the Fund's business. There can be no assurance
that payments under governmental and private third party payor programs will be
timely, will remain at levels comparable to present levels or will, in the
future, be sufficient to cover the costs allocable to patients eligible for
reimbursement pursuant to such programs. The Fund's financial condition and
results of operations may be affected by the reimbursement process, which in the
healthcare industry is complex and can involve lengthy delays between the time
that revenue is recognized and the time that reimbursement amounts are settled.

Results of Operations

    Three Months Ended June 30, 2003 versus Three Months Ended June 30, 2002

     Net earnings for the Fund were $378,000 for the three months ended June 30,
2003 as compared to $483,000 for the same period in fiscal year 2002. The
decrease in earnings is primarily due to a decrease in Private patient revenue
and increased operating costs, offset partially by a decrease in interest
expense.

     Overall revenues of $15,343,000 decreased $83,000 or .5% for the three
months ended June 30, 2003 compared to the same period in fiscal year 2002. The
decrease in revenue is primarily due to a decrease in revenues from Private
patients of $265,000, which is due to a decline in the private census. The
average daily Private census decreased 22 customers or 24.6% for the three
months ended June 30, 2003 as compared to the same period in the prior year.
Partially offsetting the decrease in Private patient revenue is an increase in
Medicaid and Medicare patients revenue. Medicaid and Medicare revenue increased
$194,000 for the three months ended June 30, 2003 compared to the same period in
the prior year. The growth in revenue is primarily due to an overall Medicaid
rate increase of approximately 5.9% driven primarily by the four Maryland
centers, which received their annual Medicaid rate adjustment in July 2002.



                                       11

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations


Results of Operations (continued)

       Second quarter 2003 expenses of $14,965,000 increased $22,000 or .15%
from the three months ended June 30, 2002.

     Operating expenses increased $269,000 or 2.1% in the second quarter of 2003
as compared to the same period in fiscal year 2002. This increase is primarily
due to the increased costs of nursing services and property and liability
insurance. Nursing costs increased $192,000 for the three months ended June 30,
2003 as compared to the same period in fiscal year 2002. This increase is
primarily due to inflationary increases in salary, wages, and employee benefits.
Property and Liability insurance increased $66,000 for the three months ended
June 30, 2003 as compared to the same period in fiscal year 2002 due to the
annual rate increase effective June. The remaining increase in operating costs
is due to general inflationary cost increases.

     Management and administrative fees of $800,000 decreased $53,000 or
approximately 6.2% for the second quarter 2003 compared to the same period in
fiscal year 2002. This decrease is due to a decrease in the management fee
expense, which is calculated at 5% of the Fund's net revenues.

     Interest expense decreased $197,000 for the three months ended June 30,
2003 as compared to the same period in fiscal year 2002. This decrease in
interest expense is due to the reduction of the interest rate from 9.75% to 6.5%
effective February 1, 2003.

      Six Months Ended June 30, 2003 versus Six Months Ended June 30, 2002

     Net earnings for the Fund were $699,000 for the six months ended June 30,
2003 as compared to $1,318,000 for the same period in fiscal year 2002,
representing a decrease of $619,000 or 47.0%.

     Overall revenues of $30,750,000 increased $256,000 or .84% for the six
months ended June 30, 2003 as compared to the same period in fiscal year 2002.
This increase in revenue is primarily due to increases in revenue from Medicaid
and Medicare patients. Medicaid and Medicare revenue increased $747,000 to
$26,385,000 for the six month period ended June 30, 2003 compared to the same
period in 2002. Medicaid revenue for the six months ended June 30, 2003
increased $1,042,000 compared to the same period in the prior year. This
increase is primarily due to an overall Medicaid rate increase of approximately
6.2% driven primarily by the four Maryland centers, which received their annual
Medicaid rate adjustment in July 2002. Medicare revenue decreased $295,000 or
3.6% for the six month period ended June 30, 2003 compared to the same period in
fiscal year 2002. This decrease is primarily due to a reduction of rates.
Private patient revenue decreased $472,000 to $4,330,000 for the six months
ended June 30, 2003 as compared to the same period in 2002. This decrease is due
to a decline in the census. The Private average daily census for the six months
ended June 30, 2003 decreased 19.3% or 18 customers compared to the same period
in fiscal year 2002.

     Overall expenses increased $875,000 or 3.0% to $30,051,000 for the six
months ended June 30, 2003 as compared to $29,176,000 for the same period in
fiscal year 2002.

     Operating expenses increased $1,405,000 or 5.7% to $26,162,000 for the six
months ended June 30, 2003 as compared to the same period in fiscal year 2002.
This increase is primarily due to the increased cost of nursing services,
ancillary costs, and property and liability insurance. Nursing costs increased
$708,000 for the six months ended June 30, 2003 as compared to the same period
in fiscal year 2002. This increase is primarily due to increases in salary,
wages, employee benefits, and supplies which is partially offset by a decrease
in the cost of temporary nurse staffing. Salary, wage, benefits, and supplies
for nursing increased $1,038,000, while temporary nurse staffing expense
decreased $330,000 for the six months ended June 30, 2003 as compared to the
same period in fiscal year 2002. Ancillary expenses for the six months ended
June 30, 2003 increased $271,000 or 7.7 % compared to the same period in fiscal
year 2002, which is attributable to the 3.1% increase in the average daily
Medicare census. Property and liability insurance increased $130,000 for the six
months ended June 30, 2003 as compared to the same period in fiscal year 2002
due to the annual rate increase effective June. The remaining increase in
operating costs is due to general inflationary cost increases.

                                       12
<PAGE>
         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations


Results of Operations (continued)

     Interest expense decreased $331,000 for the six months ended June 30, 2003
as compared to the same period in fiscal year 2002. The decrease in interest
expense is due to the reduction of the interest rate from 9.75% to 6.5%
effective February 1, 2003.

Critical Accounting Policies

     We consider an accounting policy to be critical if it is important to our
financial condition and results, and requires significant judgment and estimates
on the part of management in its application. Our critical accounting estimates
and the related assumptions are evaluated periodically as conditions warrant,
and changes to such estimates are recorded as new information or changed
conditions require revision. Application of the critical accounting policies
requires management's significant judgments, often as the result of the need to
make estimates of matters that are inherently uncertain. If actual results were
to differ materially from the estimates made, the reported results could be
materially affected. We believe that the following represents our critical
accounting policies, which are described in our most recent Annual Report on
Form 10-K:

o        Allowance for Doubtful Accounts
o        Revenue Recognition

     During the current quarter, we did not make any material changes to our
estimates or methods by which estimates are derived with regard to our critical
accounting policies.



                                       13

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP



                          PART I. FINANCIAL INFORMATION


Item 3.     Quantitative and Qualitative Disclosures About Market Risk

     The Fund has exposure to changing interest rates and is currently not
engaged in hedging activities. Interest on the Fund's $22.9 million mortgage was
at a fixed rate of 9.75% through January 31, 2003. Effective February 1, 2003
the Fund's mortgage is at a fixed rate of 6.5%.

Item 4.   Controls and Procedures

     Within the 90-day period prior to the filing of the quarterly report, an
evaluation was carried out under the supervision and with the participation of
the Fund's management, including the Chief Executive Officer (or CEO) and Chief
Financial Officer (or CFO), of the effectiveness of our disclosure controls and
procedures. Based on that evaluation, the CEO and CFO have concluded that the
Fund's disclosure controls and procedures are effective to ensure that
information required to be disclosed by the Fund in reports that it files or
submits under the Securities Exchange Act of 1934 is recorded, processed,
summarized and reported within the time periods specified in Securities and
Exchange Commission rules and forms. Subsequent to the date of their evaluation,
there were no significant changes in the Fund's internal controls or in other
factors that could significantly affect the disclosure controls, including any
corrective actions with regard to significant deficiencies and material
weaknesses.




                           PART II. OTHER INFORMATION


Item 1.     Legal Proceedings

                  Inapplicable

Item 2.     Changes in Securities and Use of Proceeds

                  Inapplicable

Item 3.     Defaults upon Senior Securities

                  Inapplicable

Item 4.     Submission of Matters to a Vote of Security Holders

                  Inapplicable

Item 5.     Other Information

                  Inapplicable




                                       14

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP



Item 6.     Exhibits and Reports on Form 8-K

a) Exhibits

   Exhibit 31.1 Certification of Principal Executive Officer Pursuant to Section
   302 of the Sarbanes-Oxley Act of 2002.

   Exhibit 31.2 Certification of Principal Financial Officer Pursuant to Section
   302 of the Sarbanes-Oxley Act of 2002.

   Exhibit 31.3 Certification of Principal Executive Officer Pursuant to Section
   302 of the Sarbanes-Oxley Act of 2002.

   Exhibit 31.4 Certification of Principal Financial Officer Pursuant to Section
   302 of the Sarbanes-Oxley Act of 2002.

   Exhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
   Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

   Exhibit 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
   Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

b) Reports on Form 8-K: None




                                       15

<PAGE>


                                                                  Exhibit 31.1

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Executive Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Robert H. Fish, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Meridian Healthcare
     Growth and Income Fund Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
     establishing and maintaining disclosure controls and procedures [as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)] for the registrant and have:

     a)  designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under our
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within those entities, particularly during the period in
         which this report is being prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls and
         procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

     c)  disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter (the registrant's fourth fiscal quarter in
         the case of an annual report) that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors (or persons performing the equivalent functions):

     a)  all significant deficiencies and material weaknesses in the design or
         operation of internal control over financial reporting which are
         reasonably likely to adversely affect the registrant's ability to
         record, process, summarize and report financial information; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the registrant's internal
         control over financial reporting.


     Date:    8/8/03               By:       /s/ Robert H. Fish
                                          Robert H. Fish
                                          Chief Executive Officer
                                          Meridian Healthcare Investments, Inc.
                                          Development General Partner

                                      -16-
<PAGE>

                                                                    Exhibit 31.2

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Financial Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, George V. Hager, Jr., certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Meridian Healthcare
     Growth and Income Fund Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
     establishing and maintaining disclosure controls and procedures [as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)] for the registrant and have:

     a)  designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under our
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within those entities, particularly during the period in
         which this report is being prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls and
         procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

     c)  disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter (the registrant's fourth fiscal quarter in
         the case of an annual report) that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors (or persons performing the equivalent functions):

     a)  all significant deficiencies and material weaknesses in the design or
         operation of internal control over financial reporting which are
         reasonably likely to adversely affect the registrant's ability to
         record, process, summarize and report financial information; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the registrant's internal
         control over financial reporting.


     Date:      8/8/03             By:    /s/  George V. Hager, Jr.
                                           George V. Hager, Jr.
                                           Chief Financial Officer
                                           Meridian Healthcare Investments, Inc.
                                           Development General Partner

                                      -17-


<PAGE>


                                                                    Exhibit 31.3

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Financial Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, John M. Prugh, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Meridian Healthcare
     Growth and Income Fund Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
     establishing and maintaining disclosure controls and procedures [as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)] for the registrant and have:

     a)  designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under our
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within those entities, particularly during the period in
         which this report is being prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls and
         procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

     c)  disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter (the registrant's fourth fiscal quarter in
         the case of an annual report) that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors (or persons performing the equivalent functions):

     a)  all significant deficiencies and material weaknesses in the design or
         operation of internal control over financial reporting which are
         reasonably likely to adversely affect the registrant's ability to
         record, process, summarize and report financial information; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the registrant's internal
         control over financial reporting.


     Date:    8/12/03               By:    /s/  John M. Prugh
                                        John M. Prugh
                                        Chief Executive Officer
                                        Brown-Healthcare, Inc.
                                        Administrative General Partner

                                      -18-

<PAGE>

                                                                    Exhibit 31.4

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Financial Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Timothy M. Gisriel, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Meridian Healthcare
     Growth and Income Fund Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
     establishing and maintaining disclosure controls and procedures [as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)] for the registrant and have:

     a)  designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under our
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within those entities, particularly during the period in
         which this report is being prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls and
         procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

     c)  disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter (the registrant's fourth fiscal quarter in
         the case of an annual report) that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors (or persons performing the equivalent functions):

     a)  all significant deficiencies and material weaknesses in the design or
         operation of internal control over financial reporting which are
         reasonably likely to adversely affect the registrant's ability to
         record, process, summarize and report financial information; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the registrant's internal
         control over financial reporting.


     Date:     8/12/03            By:    /s/  Timothy M. Gisriel
                                          Timothy M. Gisriel
                                          Chief Financial Officer
                                          Brown-Healthcare, Inc.
                                          Administrative General Partner

                                      -19-


<PAGE>


                                                                    Exhibit 32.1


                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the filing of Meridian Healthcare Growth and Income Fund
Limited Partnership's (the "Fund") Quarterly Report on Form 10-Q for the period
ending June 30, 2003 with the Securities and Exchange Commission on the date
hereof (the "Report"), We certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Fund.




Date:    8/8/03                By: /s/  Robert H. Fish
                                   Robert H. Fish
                                   Chief Executive Officer
                                   Meridian Healthcare Investments, Inc.
                                   Development General Partner


Date:    8/8/03                By:  /s/  George V. Hager, Jr.
                                   George V. Hager, Jr.
                                   Chief Financial Officer
                                   Meridian Healthcare Investments, Inc.
                                   Development General Partner




                                      -20-




<PAGE>


                                                                    Exhibit 32.2


                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                            CERTIFICATION PURSUANT TO
                                18 U.S.C.ss.1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the filing of Meridian Healthcare Growth and Income Fund
Limited Partnership's (the "Fund") Quarterly Report on Form 10-Q for the period
ending June 30, 2003 with the Securities and Exchange Commission on the date
hereof (the "Report"), We certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Fund.




Date:      8/12/03                  By:     /s/  John M. Prugh
                                        John M. Prugh
                                        Chief Executive Officer
                                        Brown-Healthcare, Inc.
                                        Administrative General Partner


Date:      8/12/03                  By:     /s/  Timothy M. Gisriel
                                        Timothy M. Gisriel
                                        Chief Financial Officer
                                        Brown-Healthcare, Inc.
                                        Administrative General Partner




                                      -21-





<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                                   SIGNATURES




Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange
Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.


                            MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                                     LIMITED PARTNERSHIP




DATE:      08/12/03                  By: /s/  John M. Prugh
                                     John M. Prugh
                                     President and Director
                                     Brown-Healthcare, Inc.
                                     Administrative General Partner




DATE:      08/12/03                  By: /s/  Timothy M. Gisriel
                                     Timothy M. Gisriel
                                     Treasurer
                                     Brown-Healthcare, Inc.
                                     Administrative General Partner



                                       22